SHARON PIRANI: Open Payments
NPI 1669173290 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 21 payments from 11 companies in 2025. Trend: 2023 $264 · 2024 $604 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 4 | $77 |
| Lilly USA, LLC | 3 | $60 |
| Novo Nordisk Inc | 3 | $56 |
| Amgen Inc. | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: ACCRUFER, MOUNJARO, Rybelsus, SHINGRIX, Kerendia, Wegovy, Veozah, FARXIGA.
Industry payments across GA — which companies pay providers there.
